Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Published
Assessing the Inventiveness of Bio-Pharmaceuticals under European and US Patent Law: A comparative study with special emphasis on DNA- & protein-related inventions
Minssen, Timo, 2012, Lund: Ineko /Intellecta AB. 430 p.Research output: Book/Report › Doctoral thesis › Research
- Published
Patenting human genes in Europe - and how it compares to the US and Australia
Minssen, Timo, 1 Jan 2017, Research Handbook on Intellectual Property and the Life Sciences. Edward Elgar Publishing, p. 26-40 15 p.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
The revival of Phage Therapy to fight Antimicrobial Resistance – Part II: What about patent protection and alternative incentives?
Minssen, Timo, 7 Aug 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO and UK Case Law: A Plausible Approach or a Mere "Hunting Licence"?
Minssen, Timo & Nilsson, D., 2016, European Intellectual Property Law: Critical Concepts in Intellectual Property Law . Rosén, J. (ed.). Cheltenham, UK: Edward Elgar Publishing, p. 164-178 15 p. (Critical Concepts in Intellectual Property Law ; No. 13).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
The fight against Antimicrobial Resistance: Important recent publications
Minssen, Timo, 31 Jul 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
Emerging Tensions at the Interface of Artificial Intelligence, IPRs & Competition Law in the Health & Life Sciences
Minssen, Timo, 2017.Research output: Contribution to conference › Conference abstract for conference › Communication
- Published
“Patenting Bioprinting Technologies in the US and Europe"
Minssen, Timo & Mimler, M., 2016.Research output: Working paper › Research
- Published
A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead
Minssen, Timo & Bostyn, Sven, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 169-173 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Happy New Year: From “Weltschmerz” to Pharmaceutical Innovation
Minssen, Timo, 31 Dec 2015Research output: Other contribution › Net publication - Internet publication › Research
- Published
Legal dimensions of Big Data in the Health and Life Sciences
Minssen, Timo, 24 May 2016Research output: Other contribution › Net publication - Internet publication › Communication
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2190
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published